Biosimilars for breast cancer treatment

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges in the manufacture, development and approval of biosimilars for breast cancer treatment.

Year of Production:
Running Time:
Color/Sound:

2015
03:17
Color/Sound

Comments are closed.